Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan
Published 2 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, Alkermes outlines its CEO succession plan following Richard Pops’ retirement announcement, leadership changes continue at Sarepta Therapeutics and Rivus Pharmaceuticals, and Boehringer Ingelheim secures an exclusive license for a preclinical small-molecule program.